《肿瘤学2020：药物研发与审批模式》 - Suppr

Suppr

超能文献

Oncology 2020: a drug development and approval paradigm.

作者信息

Dhingra K

机构信息

KAPital Consulting LLC, Sparta, NJ, USA

出版信息

Ann Oncol. 2015 Nov;26(11):2347-50. doi: 10.1093/annonc/mdv353. Epub 2015 Sep 15.

DOI:10.1093/annonc/mdv353

PMID:26374285

Abstract

摘要

相似文献

Oncology 2020: a drug development and approval paradigm.

Ann Oncol. 2015 Nov;26(11):2347-50. doi: 10.1093/annonc/mdv353. Epub 2015 Sep 15.

Tackling Cost: A Prescription for Spending Wisely.

J Natl Compr Canc Netw. 2019 Jun 1;17(6):633. doi: 10.6004/jnccn.2019.0030.

Letter to the Editor: Re: "Life Years Gained From the FDA Accelerated Approval Program in Oncology: A Portfolio Model".

J Natl Compr Canc Netw. 2024 Sep;22(7). doi: 10.6004/jnccn.2024.7043.

Oncology drug development: United States Food and Drug Administration perspective.

Crit Rev Oncol Hematol. 2002 May;42(2):137-43. doi: 10.1016/s1040-8428(02)00008-2.

Making precision oncology the standard of care.

Lancet Oncol. 2017 Jul;18(7):835. doi: 10.1016/S1470-2045(17)30474-6.

New office and new leader aim to streamline FDA cancer drug review process.

J Natl Cancer Inst. 2005 May 18;97(10):708-9. doi: 10.1093/jnci/97.10.708.

FDA approval standards for anticancer agents - lessons from two recent approvals in breast cancer.

Nat Rev Clin Oncol. 2021 Jul;18(7):397-398. doi: 10.1038/s41571-021-00504-1.

Use of Real-World Evidence to Support FDA Approval of Oncology Drugs.

Value Health. 2020 Oct;23(10):1358-1365. doi: 10.1016/j.jval.2020.06.006. Epub 2020 Sep 14.

The US Food and Drug Administration's use of regular approval for cancer drugs based on single-arm studies: implications for subsequent evidence generation.

Ann Oncol. 2018 Mar 1;29(3):527-529. doi: 10.1093/annonc/mdy008.

Clinical and Regulatory Aspects of Companion Diagnostic Development in Oncology.

Clin Pharmacol Ther. 2018 Jun;103(6):999-1008. doi: 10.1002/cpt.955. Epub 2017 Dec 20.

引用本文的文献

Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds.

Molecules. 2023 May 21;28(10):4220. doi: 10.3390/molecules28104220.

Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials.

Cancers (Basel). 2023 Jan 23;15(3):701. doi: 10.3390/cancers15030701.

Clinical trial design in the era of precision medicine.

Genome Med. 2022 Aug 31;14(1):101. doi: 10.1186/s13073-022-01102-1.

Patient Derived Ex-Vivo Cancer Models in Drug Development, Personalized Medicine, and Radiotherapy.

Cancers (Basel). 2022 Jun 18;14(12):3006. doi: 10.3390/cancers14123006.

Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents.

Evid Based Complement Alternat Med. 2022 Apr 25;2022:6201067. doi: 10.1155/2022/6201067. eCollection 2022.

Innovation in cancer therapeutics and regulatory perspectives.

Med Oncol. 2022 Feb 23;39(5):76. doi: 10.1007/s12032-022-01677-0.

First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug.

Clin Transl Sci. 2020 Jan;13(1):57-66. doi: 10.1111/cts.12678. Epub 2019 Sep 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验